Form 4: Vaxart Director Receives Stock Grant
Insider Transaction (Form 4)
W. Mark Watson, a Director of Vaxart, Inc., reported multiple transactions in common stock on July 16, 2026.
Summary
- Grant/award: acquired 39,400 Common Stock on July 16, 2026; holds 173,525 after (Direct).
- Grant/award: acquired 78,700 Stock Options (right to buy) on July 16, 2026; holds 78,700 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
W. Mark Watson — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-16 | Grant/award | Common Stock | 39,400 | — | — | 173,525 |
| 2026-07-16 | Grant/award | Stock Options (right to buy) | 78,700 | — | — | 78,700 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-16 | Grant/award (39,400 shares) |
| 2026-07-16 | Grant/award (78,700 shares) |
Keywords
insider transaction, Form 4, VXRT, Vaxart, Inc., neutral, W. Mark Watson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.